Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference32 articles.
1. American Cancer Society.http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-key-statistics. Accessed September 21, 2018.
2. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003
3. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;Griffiths;J Clin Oncol,2011
4. Optimization of patient selection for neoadjuvant chemotherapy in muscle-invasive urothelial carcinoma of the bladder;Hensley;Clin Genitourin Cancer,2018
5. Assessing cancer progression and stable disease after neoadjuvant chemotherapy for organ-confined muscle-invasive bladder cancer;Chappidi;Urology,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status;International Journal of Molecular Sciences;2024-09-13
2. A glimpse into cofilin-1 role in cancer therapy: A potential target to improve clinical outcomes?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03
3. Single-cell RNA sequencing reveals osteosarcoma microenvironment differences between chemotherapy and without chemotherapy;2023-10-03
4. Sustained complete response to first-line immunochemotherapy for highly aggressive TP53/MDM2-mutated upper tract urothelial carcinoma with ERBB2 mutations, luminal immune-infiltrated contexture, and non-mesenchymal state: a case report and literature review;Frontiers in Oncology;2023-06-23
5. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape;Société Internationale d’Urologie Journal;2022-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3